Polymorphisms of MLH1 in benign prostatic hyperplasia and sporadic prostate cancer

Biochemical and Biophysical Research Communications

Volumn 383, Issue 4, 2009, Pages 440-444

  Tanaka, Yuichiro ^a   Zaman, Mohd S ^a   Majid, Shahana ^a   Liu, Jan ^a   Kawakami, Kazumori ^a   Shiina, Hiroaki ^b   Tokizane, Takashi ^c   Dahiya, Angela V ^a   Sen, Saunak ^d   Nakajima, Koichi ^e  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b SHIMANE UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cancer; MLH1; Polymorphism; Prostate

Indexed keywords

DNA; PROTEIN MLH1;

AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; DNA REPAIR; GEL ELECTROPHORESIS; GENE FREQUENCY; GENE STRUCTURE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MISMATCH REPAIR; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE DISEASE; PROSTATE HYPERTROPHY; RISK FACTOR;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AGED; AMINO ACID SUBSTITUTION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; NUCLEAR PROTEINS; POLYMORPHISM, GENETIC; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS;

EID: 67349189451     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.04.025     Document Type: Article

References (25)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., and Thun M.J. Cancer statistics. CA, Cancer J. Clin. 58 2008 (2008) 71-96
2. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics. CA. Cancer J. Clin. 55 2005 (2002) 74-108
3. Hsieh P., and Yamane K. DNA mismatch repair: molecular mechanism, cancer, and ageing, Mech. Ageing Dev. 129 (2008) 391-407
4. Kinzler K.W., and Vogelstein B. Cancer-susceptibility genes. Gatekeepers and caretakers. Nature 386 (1997) 761-763
5. Peltomaki P., and Vasen H. Mutations associated with HNPCC predisposition-update of ICG-HNPCC/INSiGHT mutation database. Dis. Markers 20 (2004) 269-276
6. Salisbury B.A., Pungliya M., Choi J.Y., Jiang R., Sun X.J., and Stephens J.C. SNP and haplotype variation in the human genome. Mutat. Res. 526 (2003) 53-61
7. Kitagawa K., Kunugita N., Kitagawa M., and Kawamoto T. CYP2A6*6, a novel polymorphism in cytochrome p450 2A6, has a single amino acid substitution (R128Q) that inactivates enzymatic activity. J. Biol. Chem. 276 (2001) 17830-17835
8. Hanna I.H., Dawling S., Roodi N., Guengerich F.P., and Parl F.F. Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity. Cancer Res. 60 (2000) 3440-3444
9. Han H.J., Maruyama M., Baba S., Park J.G., and Nakamura Y. Genomic structure of human mismatch repair gene, hMLH1, and its mutation analysis in patients with hereditary non-polyposis colorectal cancer (HNPCC). Hum. Mol. Genet. 4 (1995) 237-242
10. Mann A., Hogdall E., Ramus S.J., DiCioccio R.A., Hogdall C., Quaye L., McGuire V., Whittemore A.S., Shah M., Greenberg D., Easton D.F., Ponder B.A., Kjaer S.K., Gayther S.A., Thompson D.J., Pharoah P.D., and Song H. Mismatch repair gene polymorphisms and survival in invasive ovarian cancer patients. Eur. J. Cancer 44 (2008) 2259-2265
11. An Y., Jin G., Wang H., Wang Y., Liu H., Li R., Wang H., Qian J., Sun W., Wang Y., Ma H., Miao R., Hu Z., Jin L., Wei Q., Shen H., Huang W., and Lu D. Polymorphisms in hMLH1 and risk of early-onset lung cancer in a southeast Chinese population. Lung Cancer 59 (2008) 164-170
12. Lee K.M., Choi J.Y., Kang C., Kang C.P., Park S.K., Cho H., Cho D.Y., Yoo K.Y., Noh D.Y., Ahn S.H., Park C.G., Wei Q., and Kang D. Genetic polymorphisms of selected DNA repair genes, estrogen and progesterone receptor status, and breast cancer risk. Clin. Cancer Res. 11 (2005) 4620-4626
13. Burmester J.K., Suarez B.K., Lin J.H., Jin C.H., Miller R.D., Zhang K.Q., Salzman S.A., Reding D.J., and Catalona W.J. Analysis of candidate genes for prostate cancer. Hum. Hered. 57 (2004) 172-178
14. Fredriksson H., Ikonen T., Autio V., Matikainen M.P., Helin H.J., Tammela T.L., Koivisto P.A., and Schleutker J. Identification of germline MLH1 alterations in familial prostate cancer. Eur. J. Cancer 42 (2006) 2802-2806
15. Lipkin S.M., Rozek L.S., Rennert G., Yang W., Chen P.C., Hacia J., Hunt N., Shin B., Fodor S., Kokoris M., Greenson J.K., Fearon E., Lynch H., Collins F., and Gruber S.B. The MLH1 D132H variant is associated with susceptibility to sporadic colorectal cancer. Nat. Genet. 36 (2004) 694-699
16. Mei Q., Yan H.L., Ding F.X., Xue G., Huang J.J., Wang Y.Z., and Sun S.H. Single-nucleotide polymorphisms of mismatch repair genes in healthy Chinese individuals and sporadic colorectal cancer patients. Cancer Genet. Cytogenet. 171 (2006) 17-23
17. Shin Y.K., Heo S.C., Shin J.H., Hong S.H., Ku J.L., Yoo B.C., Kim I.J., and Park J.G. Germline mutations in MLH1, MSH2, and MSH6 in Korean hereditary non-polyposis colorectal cancer families. Hum. Mutat. 24 (2004) 351
18. Wang Y., Friedl W., Lamberti C., Nothen M.M., Kruse R., and Propping P. A novel missense mutation in the DNA mismatch repair gene hMLH1 present among East Asians but not among Europeans. Hum. Hered. 48 (1998) 87-91
19. Kim J.C., Roh S.A., Koo K.H., Ka I.H., Kim H.C., Yu C.S., Lee K.H., Kim J.S., Lee H.I., and Bodmer W.F. Genotyping possible polymorphic variants of human mismatch repair genes in healthy Korean individuals and sporadic colorectal cancer patients. Fam. Cancer 3 (2004) 129-137
20. Moslein G., Tester D.J., Lindor N.M., Honchel R., Cunningham J.M., French A.J., Halling K.C., Schwab M., Goretzki P., and Thibodeau S.N. Microsatellite instability and mutation analysis of hMSH2 and hMLH1 in patients with sporadic, familial and hereditary colorectal cancer. Hum. Mol. Genet. 5 (1996) 1245-1252
21. Agresti A. A survey of exact inference for contingency tables. Stat. Sci. 7 (1992) 131-177
22. Shin B.Y., Chen H., Rozek L.S., Paxton L., Peel D.J., Anton-Culver H., Rennert G., Mutch D.G., Goodfellow P.J., Gruber S.B., and Lipkin S.M. Low allele frequency of MLH1 D132H in American colorectal and endometrial cancer patients. Dis. Colon Rectum 48 (2005) 1723-1727
23. Schafmayer C., Buch S., Egberts J.H., Franke A., Brosch M., El Sharawy A., Conring M., Koschnick M., Schwiedernoch S., Katalinic A., Kremer B., Fölsch U.R., Krawczak M., Fändrich F., Schreiber S., Tepel J., and Hampe J. Genetic investigation of DNA-repair pathway genes PMS2, MLH1, MSH2, MSH6, MUTYH, OGG1, and MTH1 in sporadic colon cancer. Int. J. Cancer 121 (2007) 555-558
24. Plotz G., Raedle J., Spina A., Welsch C., Stallmach A., Zeuzem S., and Schmidt C. Evaluation of the MLH1 I219V alteration in DNA mismatch repair activity and ulcerative colitis. Inflamm. Bowel Dis. 14 (2008) 605-611
25. Takahashi M., Shimodaira H., Andreutti-Zaugg C., Iggo R., Kolodner R.D., and Ishioka C. Functional analysis of human MLH1 variants using yeast and in vitro mismatch repair assays. Cancer Res. 67 (2007) 4595-4604